Latest NewsYesterday NewsQuote ListTopic ListQuote List
benzinga_article
2024.03.29 03:34
I'm PortAI, I can summarize articles.

NRX Pharmaceuticals Q4 EPS $(0.05) Beats $(0.07) Estimate

NRX Pharmaceuticals (NASDAQ:NRXP) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 68.75 percent increase over losses of $(0.16) per share from the same period last year.

NRX Pharmaceuticals (NASDAQ:NRXP) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 68.75 percent increase over losses of $(0.16) per share from the same period last year.
Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Like